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Abstract
Objective—Periodontal disease resolution was hypothesized to impact systemic HIV measures.
Methods—In this longitudinal cohort study, 73 HIV-positive subjects received comprehensive 
dental care. AAP, CDC/AAP and biofilm gingival interface case definitions determined 
periodontal classification. In a subset, IL-6 was measured. Multivariable binary logistic regression 
models estimated odds of periodontitis development for comparisons between HIV and NHANES 
(2009–12) groups.
Results—In both groups, moderate/severe periodontitis was positively associated with non-white 
race, smoking, male gender, low income and increased pro-inflammatory cytokines. Likelihood of 
HIV periodontitis was higher across demographic variables. Subjects with severe periodontitis on 
antiretroviral therapy demonstrated high plasma viral loads at baseline (median= 464 co/ml; mean 
65,773 co/ml). Post intervention, HIV periodontitis distribution became similar to NHANES and 
IL-6 levels decreased 2-fold (p=0.07). Subjects with suppressed viral load at baseline 
demonstrated increased CD4 counts at 12 months post intervention (P=0.027) (n=26).
Conclusions—Smoking, being non-white and low income were associated with periodontitis in 
HIV and NHANES. Higher Il-6, higher HIV VL and lower CD4 were associated with moderate/
severe periodontal disease. Periodontitis decreased significantly with treatment producing 
periodontal profiles mirroring the national norm. In a subset of suppressed subjects, decreased oral 
inflammation, and associated microbial translocation, yielded improved CD4 counts.
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Introduction
Oral lesions associated with human immunodeficiency virus (HIV) include oral candidiasis, 
Kaposi’s sarcoma, lymphoma and hairy leukoplakia (Greenspan & Greenspan, 2002). 
During the era of antiretroviral therapy (ART) oral human papilloma virus (HPV) and HIV 
associated salivary gland disease have been on the rise(Greenspan & Greenspan, 2002; 
Jeffers & Webster-Cyriaque, 2011). While HIV/AIDS associated periodontal lesions 
including linear gingival erythema, necrosing ulcerative periodontitis (NUP) and ulcerative 
gingivitis (NUG) are not as prevalent as pre-ART, chronic periodontitis remains an issue in 
the HIV/ AIDS population.
Along with many other systemic diseases, HIV/AIDS has been documented to impact the 
periodontium (Ryder, Nittayananta, Coogan, Greenspan, & Greenspan, 2012). Periodontitis 
is characterized by the interaction between the host immune reaction to periodontal 
pathogenic microorganisms. While largely identified as an inflammatory disease caused by 
bacteria and bacterial by-products detected in dental plaque, there is growing evidence that 
viral infections are involved in periodontal disease(Morris, Arnold, & Webster-Cyriaque, 
2007; Slots, 2002). This inflammatory process is characterized by destruction of the 
attachment apparatus surrounding the teeth. The 2009–2012 National Health and Nutrition 
Examination Survey (NHANES), estimated that 46 percent (64.7 million) of the United 
States population has periodontitis, of which 8.9 and 37.1 percent suffer from severe and 
mild-moderate forms of the disease, respectively(Eke et al., 2015). Increasing evidence 
suggests that the chronic periodontal infection is implicated in the generation of a systemic 
inflammatory response, which represents a potential risk factor for worsening various 
systemic conditions including atherosclerosis, stroke, diabetes and others(Nibali et al., 2007; 
Williams & Offenbacher, 2000)
Chronic periodontal disease has been categorized using different classification systems. The 
most widely used classification system is based on clinical attachment levels, as described 
by Armitage and adopted by the American Academy of Periodontology (AAP)(Armitage, 
1999). For the purposes of population surveillance, the Centers for Disease Control and 
Prevention developed a case classification in conjunction with the American Academy of 
Periodontology (CDC/AAP) based on periodontal probing depths and clinical attachment 
levels (Eke, Page, Wei, Thornton-Evans, & Genco, 2012). Lastly, the Biofilm Gingival 
Interface (BGI), a classification system based on bleeding on probing and probing depths, 
has been described by Offenbacher, et al(Offenbacher et al., 2007). The BGI classification 
reflects current periodontal status rather than historical levels of disease activity.
The systemic impact of HIV is multifaceted. Broad depletion of immune function allows 
susceptibility to opportunistic infections(Alarcón et al., 2012). Further, systemic immune 
activation occurs secondary to microbial translocation. The degree of immune activation is 
strongly correlated with disease progression, morbidity and mortality(Brenchley et al., 2006; 
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Hunt, 2012; Jiang et al., 2009; Klatt, Funderburg, & Brenchley, 2013; Sandler & Douek, 
2012). Decreased production of protective interleukins (IL), such as IL17 and IL22, 
decreased IgA production, and decreased phagocytic function results in the compromise of 
epithelial tight junctions throughout the GI tract(Klatt et al., 2013). This allows for escape of 
immune-activating bacterial products into the systemic circulation. While immune activation 
related microbial translocation from the GI tract has been well documented, the oral cavity 
may also serve as an important a source of microbial translocation.
The mouth may harbor over 700 different bacterial species, billions of bacteria and a 
multitude of viruses and fungi. Teeth are transmucosal, with crowns exposed to the 
contaminated oral cavity and root structures secured within maxillary and mandibular bone. 
The two environments are separated by a junctional epithelium that functions as a barrier to 
prevent the penetration of bacteria and bacterial products to underlying connective tissue and 
bone. During chronic periodontal disease, the junctional epithelial seal is widened, leading 
to the translocation of bacteria and bacterial by-products to the underlying connective tissue 
and bone(Bosshardt & Lang, 2005) Thus, chronic periodontal disease possesses the potential 
for oral microbial translocation as source of systemic inflammation. In this study, we aimed 
to compare our HIV cohort to a nationally representative sample in order to assess the effect 
of periodontal intervention on HIV population, locally and systemically.
Methods and Materials
Study Design
A cohort of 196 HIV positive subjects were followed longitudinally. This group was part of 
a multisite SPNS Oral Demonstration Project. Approval was obtained from the Institutional 
Review Boards of the University of North Carolina at Chapel Hill (UNC) and the Evaluation 
Center for HIV and Oral Health at Boston University. The multisite centers maintained 
human subjects’ approval for the overall and individual studies. Within this sub study, 48 
adult HIV-positive participants who had not received dental care, with the exception of 
emergency care, in the previous 12 months were recruited and enrolled. Additionally, 25 
HIV positive subjects who had received dental care within the past 12 months were recruited 
and enrolled. For all 73 subjects, data were collected every 6 months including periodontal 
metrics; probing depths, bleeding on probing, clinical attachment loss. Baseline, 12- and 24-
month assessments were included in this analysis and at these time points saliva was 
collected. Comprehensive dental care for the 73 participants included dental prophylaxis at 
least every 6 months, scaling and root planing, oral hygiene instruction, extractions, 
restorative and prosthetic dentistry.
The baseline interview collected data on socio demographic characteristics; mode of HIV 
transmission; past substance use, tobacco use, and alcohol use; barriers to accessing oral 
health care since testing HIV-positive; and oral health-care habits. Interviews were 
conducted in both English and Spanish, and all participants gave informed consent to 
participate. Baseline data collection occurred from January 2008 to August 2009. 
Interviewers participated in a standardized training module. Data was entered into a web-
based database hosted by the multisite coordinating center, where the data were merged into 
a single multisite database. Subjects were administered a questionnaire and received 
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comprehensive dental care as described above. Periodontal values were obtained, including 
probing depth, clinical attachment level, and bleeding on probing. All examiners were 
calibrated to a gold standard (kappa>0.9). Demographic values, smoking status, CD4 counts 
and HIV viral load were recorded. In a subset of 26 subjects, saliva samples were collected 
for measurement of pro-inflammatory cytokines.
Measures
The outcome of significance for the current analysis was periodontal status pre and post 
intervention. Using the American Academy of Periodontology (AAP) and Centers for 
Disease Control and Prevention/ American Academy of Periodontology (CDC/ AAP) and 
biofilm gingival interface (BGI) classifications, participants were classified based on 
periodontal disease severity at baseline and 12 months. Age-adjusted predicted probabilities 
for development of moderate/severe periodontal disease were determined using the 
CDC/AAP case classification from multivariable binary logistic regression models for both 
the NHANES and HIV cohorts. Relationships to demographics, smoking, HIV viral load 
and concentration of pro-inflammatory cytokines were examined.
Enzyme-linked immunosorbent assay (ELISA) for pro-inflammatory cytokines
ELISA assays were used to measure IL-6 levels (Quantikine Kit; R&D systems). Saliva was 
assayed in duplicate following manufacturer’s instructions. Concentrations of the mediator 
was determined by optical density at the manufacturer’s recommend wavelength using a 
microplate reader (Epoch microplate spectrophotometer; Biotek). Duplicate readings were 
averaged and values were multiplied by the dilution factor.
Results
One hundred and ninety six participants enrolled in the UNC HIV Demonstration project 
from 2008 to 2011 and 73 met the criteria for inclusion in this 24 month analysis. There 
were 54 men and 19 women (Figure 1). Overall the mean age of participants was 36 years, 
45 were Black non-Hispanic (NH), 24 were white non-Hispanic, 1 was Hispanic and 3 were 
of other ethnicities. At baseline, the overall CD4 mean was 517 cells/ml; median 490 
cells/ml and HIV viral load was mean 72043 copies per ml; median 62 copies/ml. In this 
cohort, 53% were non-smokers. In the NHANES 2009–12 sample, 5225 men and 5312 
women over age 30 were included, of these 1957 were Black non-Hispanic, 4420 were white 
non-Hispanic, 3517 were Hispanic and 643 were of other ethnicities (Figure 1). A subset of 
the HIV group were assessed for cytokines (n=26). Comprehensive care including oral 
examination and one on one and web based oral hygiene instruction were provided to all 73 
individuals every 6 months. All subjects were seen at least 6 month intervals. For the 73 
participants there were 293 dental prophylaxis/periodontal maintenance procedures, 19 
scaling and root planing procedures, 33 underwent periodontal debridement, 127 dental 
extractions, and 325 restorations were placed.
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Dental intervention in HIV positive participants resulted in periodontal disease distribution 
similar to that of a nationally representative sample
73 HIV positive subjects were classified according to AAP, CDC/AAP, and BGI periodontal 
disease classification systems at baseline and 12 months (Figure 2). With the AAP/ CDC 
classification, at baseline 37 of 73 subjects were classified as having moderate periodontitis, 
7/73 were severe, 11 were classified as mild and 18 of 73 were classified as having a healthy 
periodontium. After the treatment intervention 29/73 were classified as having a healthy 
periodontium, 4/73 were severe, 5/73 were mild and 35/ 73 were classified as having 
moderate periodontitis. Post-treatment the HIV group more closely approximated the 
bimodal distribution of the nationally representative NHANES 2009–10 sample, with the 
majority of subjects in the healthy (n=1976) and moderate (n=1123) categories. The 
biologically based classification, BGI, determined that the majority of the subjects had 
severe disease at baseline 46/73. Post-treatment only 1 subject remained in the severe 
disease category and there were 44/73 subjects in the diseased moderate category. The AAP 
classification at both baseline and post-intervention categorized the majority of subjects as 
having mild periodontitis, with 64/73 and 68/73 in the mild category baseline and post 
intervention, respectively. Compared to the AAP classification, the BGI and the CDC/AAP 
classifications more accurately reflected active disease and periodontal disease resolution.
In HIV infected subjects, differences in age, smoking, and income were not associated 
with development of severe periodontal disease
BGI case classifications were used to assess frequency of periodontal health, gingivitis and 
disease in the context of demographic variables. Severe periodontal disease in the HIV 
cohort was detected across all income levels and across all ages (Figure 3). An equivalent 
number of smokers and non-smokers had severe periodontal disease. Severe periodontal 
disease was detected in 70% of HIV positive non-Hispanic blacks and in 50% of HIV 
positive non-Hispanic whites. At baseline, severe periodontal disease was detected in 60% of 
men and in 20% of women with HIV infection. A higher percentage of men were detected in 
the moderate disease category.
In HIV infected subjects, the likelihood of developing moderate and severe periodontal 
disease was higher for all demographic risk factors compared to a nationally 
representative sample
Age-adjusted predicted probabilities (95% CI) of moderate/severe periodontitis were 
determined using CDC/AAP case classifications derived from multivariable binary logistic 
regression models. Estimates for men and women demonstrate a clear increased risk for men 
compared to women in the NHANES sample. In the HIV cohort the risk of periodontal 
disease development was more equivalent between genders (Figure 4A). The likelihood of 
developing moderate/severe periodontal disease was associated with increasing age in the 
NHANES sample. However, in the HIV cohort, the likelihood of developing disease was 
similar throughout the lifespan (Figure 4B). Being non-Hispanic black and Hispanic were 
associated with a higher likelihood of moderate/severe disease than being white in both the 
NHANES and HIV groups (Figure 4C). While lower annual family income was associated 
with increased likelihood of moderate/severe periodontal disease in NHANES, the 
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likelihood of periodontal disease development was high across all income strata in the HIV 
group (Figure 4D). However, at $1700 per month, the highest income strata for HIV, the 
$20,400 annual income was roughly equivalent to the lowest income group for the NHANES 
at less than $25,000 annual income. While nonsmokers were least likely to develop mod/
severe periodontal disease in NHANES, in the HIV group the likelihood of disease was 
similar regardless of smoking status (Figure 4E). Importantly, while the likelihood of 
moderate/severe disease development across different risk factors was generally in the 0.2–
0.6 range for the NHANES sample, in the HIV cohort the probability across risk factors was 
at least 2 fold higher in the 0.4 to 0.8 range.
Pro-inflammatory Cytokines were associated with increased risk of developing moderate/
severe periodontal disease
Age-adjusted predicted probabilities (95% CI) of moderate/severe periodontitis were 
determined for pro-inflammatory cytokines. C- reactive protein (CRP), an acute phase 
reactant and systemic marker of inflammation, was measured in NHANES. Those 
individuals with CRP levels in the highest tertile had the highest likelihood of periodontal 
disease (Figure 5A). The pro inflammatory cytokine IL-6 was measured in oral fluids from 
HIV positive individuals (n=26). Those individuals with highest IL-6 levels had the highest 
probability of moderate/severe periodontal disease at baseline (Figure 5B). Importantly, 
dental intervention resulted in overall decreased salivary IL-6 levels that approached 
statistical significance p=0.07. By 24 months the intervention resulted in a statistically 
significant decrease in in the moderate disease group (P=0.043) (Figure 5C). Post 
intervention IL-6 levels were also assessed in a virologically suppressed subgroup in the 
context of successful HIV therapy (Figure 5D). Mean IL-6 levels at baseline were 64.43 
pg/ml in the suppressed group (n=6). At 12 months mean IL-6 levels in this group dropped 
to 26.96 pg/ml (p=0.031).
Severe periodontal disease was associated with high HIV VLs and lower CD4 counts
At the time of the 12 month assessment 61 subjects were on ART for at least one year. 
However, 7 of the 61 individuals were within one year of their HIV diagnosis at baseline. 
The overall HIV VL at baseline was median = 139 copies /ml; mean 81,755 co/ml (n=61). 
BGI classification at baseline determined that a detectable HIV VL was present in 15 of 39 
HIV positive individuals in the severe periodontal disease group, mean 65,773 co/ml; 
median= 464 copies /ml) (N=39), and in 7 of 14 in the moderate disease group, mean= 
170,334 copies /ml; median= 49.5 copies/ml. The high mean in the moderate group was 
largely due to one individual with a baseline HIV VL of 2,340,000 copies /ml. Four subjects 
with gingivitis had an HIV VL of mean =1043 copies/ml; median =80.5 copies/ml. The four 
healthy individuals were undetectable at baseline. Baseline group assignments were used 
throughout the analysis even though several individuals changed in actual disease status at 
the time of follow-up. At 12 months, HIV VL in the severe group was mean= 8680 
copies /ml; median <49 copies /ml (undetectable), in the moderate group was mean<49 
copies /ml; median <49 copies /ml, and in subjects with gingivitis was undetectable (n=61). 
A HIV VL of mean= 5393 copies/ml; median <49 copies/ml represented a one log decrease 
in the overall mean HIV VL at 12mo (n=61) (P=.0032) (Figure 6A). Declines in viral load 
were detected by 24 months with a mean HIV VL of 337 copies/ml (P=0.0063). At baseline 
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overall CD4 levels were mean=508 cells/ml; median=466 cells/ml and rose to mean=618 
cells/ml; median=537 cells/ml at 12 months (P=0.033). At 24 months, CD4 levels rose to a 
mean= 751 cells/ml; median=730 cells/ml (P=0.0006). While CD4 increases in the moderate 
disease group were not statistically significant, CD4 cell increases the severe disease group 
were at 12 months (p=0.038) and at 24 months (p<0.01).
Improved HIV metrics could have been associated with effective ART as well as the dental 
intervention. Of the 39 subjects with severe periodontitis, there were 8 individuals in the 
severe periodontitis group who were within 1 year of their HIV diagnosis at baseline, thus 
had been on ART less than 1 year at baseline. Removal those individuals from the analysis 
demonstrated a mean HIV VL of 65,121 copies/ml; median 139 co/ml and mean CD4=546 
cells/ml at baseline, a mean HIV VL= 10,905 co/ml; median <49co/ml and mean CD4 of 
609 cells/ml at 12 months, and a mean HIV VL 441 co/ml; median <49 co/ml and mean 
CD4 of 778 cell/ml at 24 months (n=31) (Figure 6B). Overall, CD4 increases in this group 
were not statistically significant at 12 months (p=0.175), however significance was achieved 
by 24 months p=0.0003. Post intervention, CD4 changes were further assessed in the context 
of successful HIV therapy. There were 26 individuals in the moderate and severe disease 
groups at baseline with undetectable viral loads suggesting effective ART. These subjects 
had a mean CD4=517 cells/ml; median =490 cells/ml at baseline, and increased at 12 
months to mean CD4 =642 cells/ml; median=490 cells/ml. The response was assessed at 24 
months in 17 subjects who had a mean CD4= 619 cells/ml; median 500 cells/ml that 
increased at 24 months, to a mean CD4= 730 cells/ml; median 647 cells/ml. This reflected a 
sustained statistically significant increase in CD4 with the dental intervention in suppressed 
subjects (p=0.0277) (Figure 6C).
Discussion
Like the NHANES sample, smoking, being non-white and low income were associated with 
periodontal disease in HIV. Interestingly, in the HIV group, periodontal disease manifested 
across the age groups and severe disease was detected at the same rate in women and men. 
However, being HIV positive enhanced risk of having moderate/severe periodontal disease 
over and above the NHANES group for every demographic variable. Our findings were 
highly clinically relevant; dental treatment and aggressive oral hygiene in HIV resulted in a 
periodontal profile similar to that of the US healthy population. While the data do not 
remove the possibility that effective ART was responsible for viral load and CD4 count 
change, they do suggest that decreased oral infection and inflammation were associated with 
improved HIV metrics. This was confirmed in a group of twenty six subjects who were 
suppressed at baseline and demonstrated increased CD4 counts (p= 0.023) and decreased 
IL-6 (p=0.27) post intervention.
Use of a periodontal classification system that reflects the biology of disease is an important 
metric in those with a systemic inflammation-associated disorder. Distinct profiles of 
periodontal disease and disease resolution were detected comparing different periodontal 
classification systems in the HIV cohort. Inclusion of probing depths in the CDC/AAP 
classification facilitates biological relevance. At baseline, the majority of individuals were in 
the CDC/AAP severe group, treatment brought the HIV cohort to a distribution similar to 
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that of NHANES with most individuals in the CDC/AAP healthy and moderate groups. 
Inflammation is an important driver of both periodontal disease and HIV. BGI includes 
bleeding on probing as a metric, an important indicator of oral and periodontal 
inflammation. Of all classification systems, BGI demonstrated the most significant shifts 
associated with the dental intervention moving virtually all of the severe category into the 
moderate disease group by 12 months. These findings demonstrate the importance of 
including inflammation as a disease indicator. The periodontal field has now recognized the 
importance of this indicator and a recent task force was convened to address the addition of 
bleeding on probing to the AAP classification to begin 2017.
Periodontal disease is associated with circulating microbial products. Bacterial translocation 
into systemic circulation from the periodontal pocket is a common event, as supported by 
detection of bacteremia subsequent to relatively minor periodontal events and procedures. 
The massive bacterial load of the gut is thought to drive microbial translocation causing HIV 
related systemic immune activation(Brenchley et al., 2006). We posit that the mouth 
contributes to microbial translocation in HIV systemic immune activation. While 
periodontitis has been shown not to cause atherosclerotic vascular disease, periodontal 
interventions do result in reduction of systemic inflammation(Lockhart et al., 2012). In this 
study, following dental treatment, salivary levels of the systemic immune activation 
associated pro-inflammatory cytokine IL6, decreased from baseline to 12 months (p=0.07) 
reaching significance at 24 months (P=0.0115). We demonstrated in a small subset of six 
virally suppressed participants that decreased IL-6 from baseline to 12 months was not 
associated with being on ART (p=0.27). It has previously been established that while HIV 
stage was not associated with periodontal disease stage, oral hygiene was clearly associated 
with periodontal disease stage(John, Stephen, & Joyce Africa, 2013). In previous studies, 
bleeding on probing was twice as high in an antiretroviral untreated group compared to those 
on ART (P<0.001)(Fricke, Geurtsen, Staufenbiel, & Rahman, 2012) 69 of 73 individuals in 
our population were on ART and significant inflammation was detected that resolved with 
dental intervention and aggressive oral hygiene. A comprehensive care/oral hygiene 
intervention in an ART naïve group may have even more impact. The presence of detectable 
viral loads, however, may signify ineffective ART. Given that there were individuals with 
detectable viral load, on ART, we cannot rule out that a portion of these results may have 
been related to more effective ART use. At baseline, 50% of individuals on long term ART 
in the severe disease group were undetectable and by 24 months two thirds of subjects in this 
group were undetectable. Further, there is the potential that improved HIV measures could 
lead to improved dental outcomes. It has previously been shown that achievement of 
undetectable HIV VL was associated with decreased risk of co-morbid events and strongly 
associated with increased CD4 cells(Moore & Chaisson, 1999)
In this study, high plasma HIV viral loads were associated with severe periodontal disease 
(P=0.0032). Detectable viral load has been associated with the presence of oral pathogens. A 
recent Brazilian study determined that detectable HIV VL was associated with elevated 
levels of known periodontal pathogens, such as P. nigrescens, T. forsythia, and E. corrodens 
(Pereira et al., 2013). There also is the potential for a direct pathogen- pathogen relationship 
as we and others have shown that periodontal bacterial end- products can increase HIV 
replication(Kantor, Ma, Webster-Cyriaque, Monahan, & Kafri, 2009). Importantly, oral 
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antigens have been shown to facilitate trafficking of activated oral antigen specific intestinal 
T cell responses through CD18(Marski, Ye, & Abraham, 2007). Hence, periodontal antigens 
may facilitate intestinal immune activation. Low CD4 counts have previously been 
associated with chronic periodontitis in cross sectional studies(Pattrapornnan & Derouen, 
2013). In this study, a mean sustained increase in CD4 count of over 100 cells/ml was 
detected with the dental intervention in a group of subjects who were suppressed at baseline 
(p=0.02). This suggests that over and above ART, dental interventions diminishing the oral 
microbial reservoir may provide significant benefit. A major limitation, however, is the small 
sample size of the study and of the suppressed group (n=26).
Periodontal interventions in HIV significantly reduced periodontal inflammation that could 
be associated with systemic inflammation. Additional studies of systemic immune activation 
markers and periodontal disease resolution are needed. Here we describe a simple and 
relatively inexpensive dental intervention that facilitated achievement of decreased IL-6 and 
increased CD4 counts in a small subset of individuals on effective ART.
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Fig 1. HIV infected subjects demonstrated a distinct demographic profile compared to a 
nationally representative sample
Summary of demographic data for both NHANES (2009–2012) and HIV (2008–2011) at 
baseline. Percent of each group are shown based on A) Gender B) Race/ethnicity C) Income 
D) Smoking status and E) Age distribution.
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Fig 2. Biologically based indices, BGI and CDC/AAP, provided a more accurate reflection of 
periodontal disease and of disease resolution. Treatment brings HIV periodontal disease 
distribution similar to that of NHANES
Periodontal disease classification of UNC HIV Oral Demonstration population (n=73) at 
baseline and 12 mo using 3 periodontal classification systems: AAP, CDC/AAP, and BGI. 
Periodontal disease classification of NHANES 2009–10 using CDC/AAP.
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Fig 3. Differences in age, smoking, and income were not associated with development of severe 
periodontal disease by BGI stratification in the context of HIV infection
Stratification of UNC HIV cohort demographic data a) gender, B) race/ethnicity, C) income, 
D) smoking status and E) age by BGI including periodontal health, gingivitis, mild 
periodontitis (P1), moderate periodontitis (P2) and severe periodontitis (P3). Y axis reflects 
%.
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Fig 4. The likelihood of developing moderate/severe periodontal disease was higher for the HIV 
group for all demographic risk factors
Age-adjusted predicted probabilities (95% CI) of moderate/severe periodontitis using 
CDC/AAP case classifications derived from multivariable binary logistic regression models. 
Estimates are for men and women [A]; four age groups [B]; major racial/ethnic groups (non-
Hispanic white, non-Hispanic black, Hispanic, Other) [C]; categories of annual family 
income ($’000) [D]; and smoking status [E], NHANES (2009–2012) and HIV.
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Fig 5. Pro-inflammatory Cytokines increase with increasing risk of developing moderate/severe 
periodontal disease
Age-adjusted predicted probabilities (95% CI) of moderate/severe periodontitis with 
inflammatory cytokine detection. A) Plasma CRP in NHANES, B) Salivary IL-6 in HIV 
positive individuals, C) IL-6 levels stratified by BGI (at o to 12 months overall IL-6 decline 
p=o.o7) and D) IL-6 levels in suppressed subjects at baseline and 12 months.
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Fig 6. HIV VL and CD4 and plasma viral load on ART (A), on longer term ART (B) and in 
suppressed subjects (C)
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